85 related articles for article (PubMed ID: 16283030)
41. Sodium nitroprusside for advanced low-output heart failure.
Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
[TBL] [Abstract][Full Text] [Related]
42. Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction.
Cowburn PJ; Cleland JG; McArthur JD; MacLean MR; Dargie HJ; McMurray JJ; Morton JJ
Cardiovasc Res; 1998 Sep; 39(3):563-70. PubMed ID: 9861298
[TBL] [Abstract][Full Text] [Related]
43. Drug treatment of patients with decompensated heart failure.
Mills RM; Hobbs RE
Am J Cardiovasc Drugs; 2001; 1(2):119-25. PubMed ID: 14728041
[TBL] [Abstract][Full Text] [Related]
44. Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure.
Verbrugge FH; Dupont M; Finucan M; Gabi A; Hawwa N; Mullens W; Taylor DO; Young JB; Starling RC; Tang WH
Eur J Heart Fail; 2015 Sep; 17(9):956-63. PubMed ID: 26213182
[TBL] [Abstract][Full Text] [Related]
45. [Hemodynamic shifts in patients with congestive heart failure during treatment with sodium nitroprusside].
Tatishvili NI; Chkhaidze ZK; Kurashvili RB; Mamatsashvili MD; Narsiia NN
Kardiologiia; 1983 Jul; 23(7):28-31. PubMed ID: 6620808
[TBL] [Abstract][Full Text] [Related]
46. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
[TBL] [Abstract][Full Text] [Related]
47. [Vasodilator treatment of left ventricular insufficiency in the acute stage of myocardial infarction].
Fauvel JM; Donzeau JP; Bounhoure JP; Bernadet P; Calazel P
Arch Mal Coeur Vaiss; 1977 Aug; 70(8):825-32. PubMed ID: 409363
[TBL] [Abstract][Full Text] [Related]
48. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
[TBL] [Abstract][Full Text] [Related]
49. Hemodynamic, ventilatory and blood gas changes during infusion of sodium nitroferricyanide (nitroprusside). Studies in patients with congestive heart failure.
Mookherjee S; Keighley JF; Warner RA; Bowser MA; Obeid AI
Chest; 1977 Sep; 72(3):273-8. PubMed ID: 891277
[TBL] [Abstract][Full Text] [Related]
50. [Use of vasodilator agents for treating acute cardiac insufficiency].
Gratsianskiĭ NA; Karpov IuA; Ruda MIa
Kardiologiia; 1980 Oct; 20(10):25-31. PubMed ID: 6777574
[TBL] [Abstract][Full Text] [Related]
51. [Clinical and hemodynamic efficacy of enalapril in severe congestive heart failure].
Catarino C; Serra J; Antunes E; Ferreira R; da Silva N; de Oliveira M; Lousada N; Faria J; Quininha J; Gracias R
Rev Port Cardiol; 1990 Dec; 9(12):969-71. PubMed ID: 2093336
[TBL] [Abstract][Full Text] [Related]
52. Perioperative intra- and extravascular volume in liver transplant recipients.
Costa MG; Girardi L; Pompei L; Chiarandini P; De Flaviis A; Lugano M; Mattelig S; Tripi G; Vetrugno L; Baccarani U; Scudeller L; Della Rocca G
Transplant Proc; 2011 May; 43(4):1098-102. PubMed ID: 21620062
[TBL] [Abstract][Full Text] [Related]
53. Aortic input impedance during nitroprusside infusion. A reconsideration of afterload reduction and beneficial action.
Pepine CJ; Nichols WW; Curry RC; Conti CR
J Clin Invest; 1979 Aug; 64(2):643-54. PubMed ID: 457874
[TBL] [Abstract][Full Text] [Related]
54. [Nitrates in heart failure: the hemodynamic effects and clinical implications].
Faggiano P; Rusconi C; Ghizzoni G
Cardiology; 1994; 84 Suppl 1():52-63. PubMed ID: 8087825
[TBL] [Abstract][Full Text] [Related]
55. [Pulmonary artery pressure sensor for ambulatory assessment of ventricular filling pressure in advanced heart failure : What should be considered for the follow-up care?].
Herrmann E; Ecke A; Fichtlscherer S; Zeiher AM; Assmus B
Herzschrittmacherther Elektrophysiol; 2018 Dec; 29(4):393-400. PubMed ID: 30306304
[TBL] [Abstract][Full Text] [Related]
56. The cardiovascular safety of sodium nitroprusside in acute heart failure.
Bocchino PP; Angelini F; Gallone G; Frea S; De Ferrari GM
Expert Opin Drug Saf; 2024 Jun; 23(6):663-666. PubMed ID: 38661629
[No Abstract] [Full Text] [Related]
57. Hemodynamic testing to guide vasodilator therapy in cardiac amyloidosis.
Rucker DM; Siddiqi OK; Pimentel DR; Luptak I
J Cardiol Cases; 2023 Sep; 28(3):105-108. PubMed ID: 37671260
[TBL] [Abstract][Full Text] [Related]
58. Advanced Hemodynamic Monitoring Allows Recognition of Early Response Patterns to Diuresis in Congestive Heart Failure Patients.
Dagan M; Kolben Y; Goldstein N; Ben Ishay A; Fons M; Merin R; Eisenkraft A; Amir O; Asleh R; Ben-Yehuda A; Nachman D
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614848
[TBL] [Abstract][Full Text] [Related]
59. Invasive versus non-invasive hemodynamic monitoring of heart failure patients and their outcomes.
Kandah F; Dhruva P; Shukla R; Ganji M; Palacio C; Missov E; Ruiz-Morales J
J Geriatr Cardiol; 2022 Apr; 19(4):315-318. PubMed ID: 35572217
[No Abstract] [Full Text] [Related]
60. Correction to: "Socioeconomic Disparities in Referral for Invasive Hemodynamic Evaluation for Advanced Heart Failure: A Nationwide Cohort Study".
Circ Heart Fail; 2022 Mar; 15(3):e000073. PubMed ID: 35290093
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
